Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 1,201 shares of common stock on 02/21/2024, with an aggregate market value of $506,545.77. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Morrow over the past three months, totaling 1,714 shares for gross proceeds of approximately $720,731.91.
Vertex Pharmaceuticals Inc. officer, Atkinson Edward Morrow III, is set to sell 1,201 shares of common stock on 02/21/2024, with an aggregate market value of $506,545.77. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Morrow over the past three months, totaling 1,714 shares for gross proceeds of approximately $720,731.91.